Askanas, Valerie; Engel, W King; Nogalska, Anna (2009) Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation. Brain Pathol 19:493-506
|
Askanas, Valerie; Engel, W King (2008) Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains. Acta Neuropathol 116:583-95
|
Askanas, Valerie; Engel, W King (2007) Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis. Curr Opin Rheumatol 19:550-9
|
Engel, W King; Askanas, Valerie (2006) Inclusion-body myositis: clinical, diagnostic, and pathologic aspects. Neurology 66:S20-9
|
Askanas, Valerie; Engel, W King (2006) Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition. Neurology 66:S39-48
|
Askanas, Valerie; Engel, W King (2003) Unfolding story of inclusion-body myositis and myopathies: role of misfolded proteins, amyloid-beta, cholesterol, and aging. J Child Neurol 18:185-90
|
Askanas, Valerie; Engel, W King (2003) Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-beta, misfolded proteins, predisposing genes, and aging. Curr Opin Rheumatol 15:737-44
|
Askanas, Valerie; Engel, W King (2002) Newest pathogenetic considerations in inclusion-body myositis: possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease. Curr Rheumatol Rep 4:427-33
|
Askanas, Valerie; Engel, W King (2002) Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms. Curr Opin Neurol 15:525-31
|
Askanas, V; Engel, W K (2001) Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease. J Neuropathol Exp Neurol 60:1-14
|
Showing the most recent 10 out of 17 publications